Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
21.62
-2.76 (-11.32%)
At close: Jun 5, 2026, 4:00 PM EDT
21.52
-0.10 (-0.46%)
After-hours: Jun 5, 2026, 4:10 PM EDT
Surrozen Market Cap
Surrozen has a market cap or net worth of $249.86 million as of June 5, 2026. Its market cap has increased by 299.18% in one year.
Market Cap
249.86M
Enterprise Value
149.72M
1-Year Change
299.18%
Ranking
Category
Stock Price
$21.62
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $249.86M, an increase of 107.09%. That is a compound annual growth rate of 14.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 249.86M | 18.59% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 304.51M |
| Lineage Cell Therapeutics | 301.65M |
| Bicycle Therapeutics | 298.09M |
| InflaRx | 294.59M |
| Immuneering | 289.84M |
| Inhibikase Therapeutics | 282.90M |
| Armata Pharmaceuticals | 282.19M |
| Niagen Bioscience | 279.34M |